Patents Assigned to Biomune, Inc.
  • Tumor and infectious disease therapeutic compositions
    Patent number: 9035033
    Abstract: A pharmaceutical composition comprising lectins is anti-tumorigenic and anti-viral, bacterial or protozoan. The composition, termed BiOmune is also useful for imaging, diagnosis and therapy of cancer.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: May 19, 2015
    Assignee: BIOMUNE, INC.
    Inventor: James Spencer Lipton
  • TUMOR AND INFECTIOUS DISEASE THERAPEUTIC COMPOSITIONS
    Publication number: 20120141560
    Abstract: A pharmaceutical composition comprising lectins is anti-tumorigenic and anti-viral, bacterial or protozoan. The composition, termed BiOmune is also useful for imaging, diagnosis and therapy of cancer.
    Type: Application
    Filed: February 13, 2012
    Publication date: June 7, 2012
    Applicant: BIOMUNE, INC.
    Inventor: James Spencer LIPTON
  • Tumor and infectious disease therapeutic compositions
    Patent number: 8114972
    Abstract: A pharmaceutical composition comprising lectins is anti-tumorigenic and anti-viral, bacterial or protozoan. The composition, termed BiOmune is also useful for imaging, diagnosis and therapy of cancer.
    Type: Grant
    Filed: February 25, 2008
    Date of Patent: February 14, 2012
    Assignee: Biomune, Inc.
    Inventor: James Spencer Lipton
  • Cancer therapeutic compositions
    Publication number: 20060120997
    Abstract: A pharmaceutical composition comprising lectins is anti-tumorigenic. The composition is used in imaging, diagnosis and therapy of cancer.
    Type: Application
    Filed: October 31, 2005
    Publication date: June 8, 2006
    Applicant: BIOMUNE, INC.
    Inventor: James Lipton